SynBiotic SE

Strategic Partner in Cannabis Innovation

Background

SynBiotic SE is one of Europe’s leading cannabis platforms for investments, focused on building a safe, science-driven cannabinoid economy. They combine pharma-grade production with strategic investment in next-gen cannabis technologies.

SynBiotic is a German-based, publicly listed enterprise (XETRA: SBX) and one of Europe’s most comprehensive cannabis/hemp platforms. With subsidiaries spanning research, pharma, nutraceuticals, and consumer goods, SynBiotic’s mission is to create a safer and more sustainable future through cannabinoid-based innovation.

The company strategically partners with leaders across the value chain, from cultivation to medical distribution. Its alignment with GOC Nexus supports mutual goals in EU-GMP certification, pharmaceutical cannabis processing, and the advancement of evidence-based cannabinoid applications.